» Articles » PMID: 38248024

Predicting the Invasiveness of Pulmonary Adenocarcinomas in Pure Ground-Glass Nodules Using the Nodule Diameter: A Systematic Review, Meta-Analysis, and Validation in an Independent Cohort

Overview
Specialty Radiology
Date 2024 Jan 22
PMID 38248024
Authors
Affiliations
Soon will be listed here.
Abstract

The nodule diameter was commonly used to predict the invasiveness of pulmonary adenocarcinomas in pure ground-glass nodules (pGGNs). However, the diagnostic performance and optimal cut-off values were inconsistent. We conducted a meta-analysis to evaluate the diagnostic performance of the nodule diameter for predicting the invasiveness of pulmonary adenocarcinomas in pGGNs and validated the cut-off value of the diameter in an independent cohort. Relevant studies were searched through PubMed, MEDLINE, Embase, and the Cochrane Library, from inception until December 2022. The inclusion criteria comprised studies that evaluated the diagnostic accuracy of the nodule diameter to differentiate invasive adenocarcinomas (IAs) from non-invasive adenocarcinomas (non-IAs) in pGGNs. A bivariate mixed-effects regression model was used to obtain the diagnostic performance. Meta-regression analysis was performed to explore the heterogeneity. An independent sample of 220 pGGNs (82 IAs and 128 non-IAs) was enrolled as the validation cohort to evaluate the performance of the cut-off values. This meta-analysis finally included 16 studies and 2564 pGGNs (761 IAs and 1803 non-IAs). The pooled area under the curve, the sensitivity, and the specificity were 0.85 (95% confidence interval (CI), 0.82-0.88), 0.82 (95% CI, 0.78-0.86), and 0.73 (95% CI, 0.67-0.78). The diagnostic performance was affected by the measure of the diameter, the reconstruction matrix, and patient selection bias. Using the prespecified cut-off value of 10.4 mm for the mean diameter and 13.2 mm for the maximal diameter, the mean diameter showed higher sensitivity than the maximal diameter in the validation cohort (0.85 vs. 0.72, < 0.01), while there was no significant difference in specificity (0.83 vs. 0.86, = 0.13). The nodule diameter had adequate diagnostic performance in differentiating IAs from non-IAs in pGGNs and could be replicated in a validation cohort. The mean diameter with a cut-off value of 10.4 mm was recommended.

Citing Articles

Assessment of intratumor heterogeneity for preoperatively predicting the invasiveness of pulmonary adenocarcinomas manifesting as pure ground-glass nodules.

Qi H, Zuo Z, Lin S, Chen Y, Li H, Hu D Quant Imaging Med Surg. 2025; 15(1):272-286.

PMID: 39839051 PMC: 11744125. DOI: 10.21037/qims-24-734.


Exploration of optimal thresholds for predicting the invasive nature of stage T1 lung adenocarcinoma using artificial intelligence-based 3D solid component volume segmentation.

Shi W, Hu Y, Sun Y, Chang G, Yang Y, Song Y Quant Imaging Med Surg. 2025; 15(1):249-258.

PMID: 39839017 PMC: 11744170. DOI: 10.21037/qims-24-1627.


Predicting High-Grade Patterns in Stage I Solid Lung Adenocarcinoma: A Study of 371 Patients Using Refined Radiomics and Deep Learning-Guided CatBoost Classifier.

Zheng H, Chen W, Liu J, Jian L, Luo T, Yu X Technol Cancer Res Treat. 2024; 23:15330338241308610.

PMID: 39692551 PMC: 11660076. DOI: 10.1177/15330338241308610.


Imaging diagnostics of pulmonary ground-glass nodules: a narrative review with current status and future directions.

Luo W, Ren Y, Liu Y, Deng J, Huang X Quant Imaging Med Surg. 2024; 14(8):6123-6146.

PMID: 39144060 PMC: 11320543. DOI: 10.21037/qims-24-674.

References
1.
Higgins J, Thompson S . Quantifying heterogeneity in a meta-analysis. Stat Med. 2002; 21(11):1539-58. DOI: 10.1002/sim.1186. View

2.
Ding H, Shi J, Zhou X, Xie D, Song X, Yang Y . Value of CT Characteristics in Predicting Invasiveness of Adenocarcinoma Presented as Pulmonary Ground-Glass Nodules. Thorac Cardiovasc Surg. 2016; 65(2):136-141. DOI: 10.1055/s-0036-1587592. View

3.
Mazzone P, Silvestri G, Souter L, Caverly T, Kanne J, Katki H . Screening for Lung Cancer: CHEST Guideline and Expert Panel Report. Chest. 2021; 160(5):e427-e494. PMC: 8727886. DOI: 10.1016/j.chest.2021.06.063. View

4.
Page M, McKenzie J, Bossuyt P, Boutron I, Hoffmann T, Mulrow C . The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021; 372:n71. PMC: 8005924. DOI: 10.1136/bmj.n71. View

5.
Wang H, Weng Q, Hui J, Fang S, Wu X, Mao W . Value of TSCT Features for Differentiating Preinvasive and Minimally Invasive Adenocarcinoma From Invasive Adenocarcinoma Presenting as Subsolid Nodules Smaller Than 3 cm. Acad Radiol. 2019; 27(3):395-403. DOI: 10.1016/j.acra.2019.05.005. View